281217
Evaluating the impact of strategies to prevent second hand smoke exposure in multi-unit housing (MUH) complexes
Monday, November 4, 2013
: 9:10 a.m. - 9:30 a.m.
Brian King, PhD, MPH,
Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, GA
Exposure to second-hand tobacco smoke is an important public health problem in the U.S. In many jurisdictions, multi-unit housing (MUH) complexes are one of the largest venues for exposure to second-hand smoke, either in common areas, in residential units, or from smoke entering apartments from other areas. Multiple jurisdictions funded by the Communities Putting Prevention to Work (CPPW) and Community Transformation Grants (CTG) initiatives are providing public health and evaluation support to multi-unit housing complexes (both public and private) that wish to limit these sources of second-hand smoke exposure by becoming comprehensive non-smoking facilities. This presentation will discuss the processes and contextual factors involved in making MUH complexes smoke-free across CPPW and CTG communities, the different ways to evaluate smoke-free multi-unit housing, and the ways smoke-free MUH affects resident attitudes, smoking behaviors, and exposure to second-hand smoke.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practice
Public health or related research
Learning Objectives:
Describe the processes and contextual factors involved in making multi-unit housing complexes smoke-free.
Discuss different ways to evaluate smoke-free multi-unit housing.
Evaluate the ways smoke-free multi-unit housing affect resident attitudes, smoking behaviors, and exposure to second-hand smoke.
Keyword(s): Smoking, Evaluation
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I have 20 years of experience in tobacco control that includes developing, managing, and evaluating programs at the local, state, and federal level.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
